(S,Z)-3-(2-((1R,3aS,7aR)-7a-methyl-1-((R)-6-methylheptan-2-yl)dihydro-1H-inden-4(2H,5H,6H,7H,7aH)-ylidene)ethylidene)-4-methylenecyclohexanol (Compound)

Description: A compound in the knowledge graph

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View (S,Z)-3-(2-((1R,3aS,7aR)-7a-methyl-1-((R)-6-methylheptan-2-yl)dihydro-1H-inden-4(2H,5H,6H,7H,7aH)-ylidene)ethylidene)-4-methylenecyclohexanol's neighborhood in the knowledge graph.

Submit

Knowledge Graph Assertions

Source	Relation	Target	Evidence
(S,Z)-3-(2-((1R,3aS,7aR)-7a-methyl-1-((R)-6-methylheptan-2-yl)dihydro-1H-inden-4(2H,5H,6H,7H,7aH)-ylidene)ethylidene)-4-methylenecyclohexanol Compound (Entity type)	Indication Knowledge Graph Relation (Entity type)	Osteoporosis, Postmenopausal Disease or Phenotype (Entity type)
(S,Z)-3-(2-((1R,3aS,7aR)-7a-methyl-1-((R)-6-methylheptan-2-yl)dihydro-1H-inden-4(2H,5H,6H,7H,7aH)-ylidene)ethylidene)-4-methylenecyclohexanol Compound (Entity type)	Indication Knowledge Graph Relation (Entity type)	Hypoparathyroidism Disease or Phenotype (Entity type)
(S,Z)-3-(2-((1R,3aS,7aR)-7a-methyl-1-((R)-6-methylheptan-2-yl)dihydro-1H-inden-4(2H,5H,6H,7H,7aH)-ylidene)ethylidene)-4-methylenecyclohexanol Compound (Entity type)	Bioactivity Knowledge Graph Relation (Entity type)	Glycine receptor subunit alpha-1 Protein (Entity type)	EC50
(S,Z)-3-(2-((1R,3aS,7aR)-7a-methyl-1-((R)-6-methylheptan-2-yl)dihydro-1H-inden-4(2H,5H,6H,7H,7aH)-ylidene)ethylidene)-4-methylenecyclohexanol Compound (Entity type)	Bioactivity Knowledge Graph Relation (Entity type)	Vitamin D3 receptor Protein (Entity type)	EC50
(S,Z)-3-(2-((1R,3aS,7aR)-7a-methyl-1-((R)-6-methylheptan-2-yl)dihydro-1H-inden-4(2H,5H,6H,7H,7aH)-ylidene)ethylidene)-4-methylenecyclohexanol Compound (Entity type)	Indication Knowledge Graph Relation (Entity type)	Osteomalacia Disease or Phenotype (Entity type)
(S,Z)-3-(2-((1R,3aS,7aR)-7a-methyl-1-((R)-6-methylheptan-2-yl)dihydro-1H-inden-4(2H,5H,6H,7H,7aH)-ylidene)ethylidene)-4-methylenecyclohexanol Compound (Entity type)	Indication Knowledge Graph Relation (Entity type)	Vitamin D Deficiency Disease or Phenotype (Entity type)
(S,Z)-3-(2-((1R,3aS,7aR)-7a-methyl-1-((R)-6-methylheptan-2-yl)dihydro-1H-inden-4(2H,5H,6H,7H,7aH)-ylidene)ethylidene)-4-methylenecyclohexanol Compound (Entity type)	Indication Knowledge Graph Relation (Entity type)	Hypocalcemia Disease or Phenotype (Entity type)
(S,Z)-3-(2-((1R,3aS,7aR)-7a-methyl-1-((R)-6-methylheptan-2-yl)dihydro-1H-inden-4(2H,5H,6H,7H,7aH)-ylidene)ethylidene)-4-methylenecyclohexanol Compound (Entity type)	Indication Knowledge Graph Relation (Entity type)	Prevention of dental caries Disease or Phenotype (Entity type)
(S,Z)-3-(2-((1R,3aS,7aR)-7a-methyl-1-((R)-6-methylheptan-2-yl)dihydro-1H-inden-4(2H,5H,6H,7H,7aH)-ylidene)ethylidene)-4-methylenecyclohexanol Compound (Entity type)	Indication Knowledge Graph Relation (Entity type)	Vitamin Deficiency Disease or Phenotype (Entity type)
(S,Z)-3-(2-((1R,3aS,7aR)-7a-methyl-1-((R)-6-methylheptan-2-yl)dihydro-1H-inden-4(2H,5H,6H,7H,7aH)-ylidene)ethylidene)-4-methylenecyclohexanol Compound (Entity type)	Indication Knowledge Graph Relation (Entity type)	Osteoporosis Disease or Phenotype (Entity type)